This compound is a macrolide antibiotic active pharmaceutical ingredient used in pharmaceutical manufacturing. Its complex structure includes multiple hydroxyl groups, ether linkages, and stereocenters, reflecting its specialized role in antibiotic production.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Erythromycin EP Impurity L
pharmaceutical raw material
Erythromycin f
pharmaceutical raw material
Flurazepam Monohydrochloride EP Impurity C
pharmaceutical raw material
2-aminothiazole
Active pharmaceutical ingredient
(RS)-eflornithine hydrochloride hydrate
pharmaceutical raw material
Vortioxetine hydrobromide
pharmaceutical raw material
Erythromycin
pharmaceutical raw material
Erythromycin lactobionate
pharmaceutical raw material
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-6-[3-hydroxy-6-methyl-4-[methyl(trideuterio(113C)methyl)amino]oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
ULGZDMOVFRHVEP-ZFHWVPMOSA-N
[2H][13C]([2H])([2H])N(C)C1CC(OC(C1O)O[C@@H]2[C@H]([C@@H]([C@H](C(=O)O[C@@H]([C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]2(C)O)C)C)O)(C)O)CC)C)OC3CC(C(C(O3)C)O)(C)OC)C)C
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.